scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JURO.2009.01.029 |
P8608 | Fatcat ID | release_ajnbi3drhnajrd5uzrbn3u4nsy |
P932 | PMC publication ID | 3677190 |
P698 | PubMed publication ID | 19286205 |
P5875 | ResearchGate publication ID | 24200793 |
P50 | author | Donna Ankerst | Q58241772 |
P2093 | author name string | Ian M Thompson | |
Brad H Pollock | |||
Dipen J Parekh | |||
Prakash Vijay Nair | |||
Ryan Miyamoto | |||
P2860 | cites work | Cancer statistics, 2008 | Q27860585 |
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. | Q34291551 | ||
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter | Q34323096 | ||
The influence of finasteride on the development of prostate cancer | Q34534815 | ||
Controversies regarding screening for prostate cancer | Q36861719 | ||
Active surveillance for favorable risk prostate cancer: rationale, risks, and results | Q37019376 | ||
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial | Q39710858 | ||
Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial | Q39752227 | ||
Assessing individual risk for prostate cancer | Q39809092 | ||
Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam. | Q39842824 | ||
The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer. | Q39842989 | ||
The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam | Q39843624 | ||
Radical Prostatectomy for Impalpable Prostate Cancer: The Johns Hopkins Experience With Tumors Found on Transurethral Resection (Stages T1a and T1b) and on Needle Biopsy (Stage T1c) | Q40393478 | ||
Biological variation of prostate specific antigen levels in serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients | Q41467228 | ||
Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. | Q46032140 | ||
Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations | Q73444570 | ||
European Randomized Study of Screening for Prostate Cancer: achievements and presentation | Q76382506 | ||
Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome | Q79426082 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2071-5; discussion 2076 | |
P577 | publication date | 2009-03-14 | |
P1433 | published in | Journal of Urology | Q15709979 |
P1476 | title | Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population | |
P478 | volume | 181 |
Q36986295 | Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. |
Q37537786 | Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis |
Q36235155 | Prostate cancer screening trends in a large, integrated health care system |
Q40852349 | Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer |
Q36942855 | Trends and co-trends of prostate-specific antigen and body mass index in a screened population |
Q36607766 | Tumor markers in prostate cancer I: blood-based markers |
Q34164258 | What happens after an elevated PSA test: the experience of 13,591 veterans |
Search more.